EC Number |
Inhibitors |
Structure |
---|
1.1.1.213 | (2E)-3-(4-bromophenyl)-2-[4-(methylsulfonyl)phenyl]prop-2-enoic acid |
93.3% inhibition at 0.1 mM |
|
1.1.1.213 | (2E)-3-(4-ethylphenyl)-2-[4-(methylsulfonyl)phenyl]prop-2-enoic acid |
89.1% inhibition at 0.1 mM |
|
1.1.1.213 | (2E)-3-(4-methylphenyl)-2-[4-(methylsulfonyl)phenyl]prop-2-enoic acid |
92.7% inhibition at 0.1 mM |
|
1.1.1.213 | (2E)-3-[4-(methylsulfanyl)phenyl]-2-[4-(methylsulfonyl)phenyl]prop-2-enoic acid |
93.5% inhibition at 0.1 mM |
|
1.1.1.213 | (E/Z)-sulfindac |
wild-type, W86Y and W227Y |
|
1.1.1.213 | 1,10-phenanthroline |
wild-type, W86Y and W227Y |
|
1.1.1.213 | 1,7-phenanthroline |
wild-type, W86Y and W227Y |
|
1.1.1.213 | 1-(4'nitrophenyl)prop-2-en-1-ol |
inactivation dependent on NAD+ concentration, optimal at 0.5-1.0 mM NAD+, 2-mercaptoethanol prvides a concentration-dependent protection |
|
1.1.1.213 | 1-(4'nitrophenyl)prop-2-en-1-one |
inactivation can be retarded markedly in a concentration-dependent manner by both NADH and NADPH. Competitive inhibitor of NAD+ binding, measured for androsterone oxidation |
|
1.1.1.213 | 1-(4'nitrophenyl)prop-2-yn-1-one |
competitive inhibitor of NAD+ binding, measured for androsterone oxidation |
|